Are You Becoming A Caffeine Java Zombie?

Coffee helps get millions of people out of bed and even past the lunch slump. But, could America's favorite caffeine beverage be turning people into addicted Java Zombies?

Researchers at the University of Texas Southwestern Medical Center identified a biochemical reaction shared in the brains of all mammals. They apparently are able to follow a chemical trail left behind by prolonged neural (nerve) activity in the brain cells. This tell-tale chemical signal seems to mark the doorway between being awake and being asleep.

Hidden Deep Within The Electro-Chemical Wrinkles Of The Brain Is A Kind Of Mental Twilight Zone

This explains why so many people depend on coffee to stay alert. The caffeine in coffee can actually counteract the adenosine (structure of an acid), but it may take as long as an hour or two to kick in. Meanwhile, you are left somewhere between awake and asleep — a dangerous place to be if you're operating heavy equipment or working in an airport flight control tower.

This process of falling asleep and waking up depends on the “pleasure centers” within the brain. It appears that when you're awake, your pleasure center releases a neurotransmitter called glutamate. That means it acts as a messenger which excites brain cells, keeping them actively communicating while your awake.

Sponsored Link

Can’t Live With Insomnia? Now You’ll Never Have To Again!

Insomnia is NOT something you need to “learn to live with,” even if you’ve been plagued by insomnia for years and tried just about everything.

I’ve discovered (after a lot of research) that a few simple changes, along with a specific brain technology, can be all you need to restore your body’s innate ability to sleep naturally.

Hello, my name is Yan Muckle, founder of SleepTracks, I also developed a powerful and easy way to get asleep faster – at least that's what the vast majority of people who've tried it say.

Click Here To Learn How Thousands Have Escaped Insomnia’s Vicious Circle.

Caffeine Stimulates Your Brain's Pleasure Center To Make More Glutamate

There is another neurotransmitter that nerve cells make called adenosine, which quiets brain cells down, making you fall asleep. Adenosine is like a safety feature built in to the brain to keep you from staying awake too long.

So, regardless of how much coffee you drink, eventually you're going to find yourself caught between the Netherlands of conscious and unconscious. Trying to push your limits using any chemical stimulant, as you know, is risky at best — whether it's to get some sleep or stay awake.

Sooner or later we all have to, “Pay the Cappuccino vendor” one way or another.

It's better to find a natural balance by learning how to increase real energy levels.

Tuning in to your natural Circadian cycle is the key to sleeping well and being alert and awake when need be. Once this balance is disturbed, it's hard to get it back again.

Caffeine Is A Central Nerve Stimulant, Which Changes Natural Behavior Patterns (1)

What happens when you can't get your coffee fix, then what? Yes, The FDA labels caffeine as a mild brain stimulant and isn't labeled as addictive. Unfortunately, many people are addicted; maybe you are, too.

Some Of Caffeine's Withdrawal Symptoms:

  • Headache
  • Fatigue
  • Brain Fog
  • Drowsiness

How do you behave if you can't get yours? It's NOT a happy place, is it?

You can create more energy, naturally, instead of just stimulating the little you have by using ancient breathing techniques, eating raw foods and getting out in the sun for some mild exercise.

When comparing apples to apples, caffeine is a drug. After all, caffeine isn't an essential nutrient, is it?

P.S. Curiously, the Diagnostic and Statistical Manual for Mental Disorders (1994), “a non-scientific document” published by a board of psychologists to promote drugs, does not list caffeine as a substance that causes addiction.

Reference:
1)     Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions by Suzette M. Evans and Roland R. Griffiths. Published In: THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 289, No. 1
zp8497586rq

Comments

comments